Medicinal and genetic approaches to the treatment of mitochondrial disease

被引:36
作者
Schon, EA
DiMauro, S
机构
[1] Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA
[2] Columbia Univ, Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA
关键词
MELAS; mtDNA; nitric oxide; nitroglycerin; oxidative phosphorylation; therapy; respiratory chain;
D O I
10.2174/0929867033456503
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Although great progress has been made in our understanding of the molecular bases of mitochondrial disorders due to defects in the respiratory chain, little exists in the way of rational therapy. Possible therapeutic approaches include: palliative therapy; removal of noxious metabolites; administration of artificial electron acceptors, metabolites, and free radical scavengers; genetic counseling; and gene therapy. There has been progress with each of these approaches, although much work remains to be done. Finally, a novel approach to treating a specific mitochondrial disorder, MELAS, is presented.
引用
收藏
页码:2523 / 2533
页数:11
相关论文
共 105 条
  • [1] Effect of coenzyme Q10 in patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): Evaluation by noninvasive tissue oximetry
    Abe, K
    Matsuo, Y
    Kadekawa, J
    Inoue, S
    Yanagihara, T
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 1999, 162 (01) : 65 - 68
  • [2] KEARNS-SAYRE SYNDROME WITH REDUCED PLASMA AND CEREBROSPINAL-FLUID FOLATE
    ALLEN, RJ
    DIMAURO, S
    COULTER, DL
    PAPADIMITRIOU, A
    ROTHENBERG, SP
    [J]. ANNALS OF NEUROLOGY, 1983, 13 (06) : 679 - 682
  • [3] SEQUENCE AND ORGANIZATION OF THE HUMAN MITOCHONDRIAL GENOME
    ANDERSON, S
    BANKIER, AT
    BARRELL, BG
    DEBRUIJN, MHL
    COULSON, AR
    DROUIN, J
    EPERON, IC
    NIERLICH, DP
    ROE, BA
    SANGER, F
    SCHREIER, PH
    SMITH, AJH
    STADEN, R
    YOUNG, IG
    [J]. NATURE, 1981, 290 (5806) : 457 - 465
  • [4] Exercise intolerance due to mutations in the cytochrome b gene of mitochondrial DNA
    Andreu, AL
    Hanna, MG
    Reichmann, H
    Bruno, C
    Penn, AS
    Tanji, K
    Pallotti, F
    Iwata, S
    Bonilla, E
    Lach, B
    Morgan-Hughes, J
    DiMauro, S
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (14) : 1037 - 1044
  • [5] Evaluation of bupivacaine-induced muscle regeneration in the treatment of ptosis in patients with chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome
    Andrews, RM
    Griffiths, PG
    Chinnery, PF
    Turnbull, DM
    [J]. EYE, 1999, 13 (6) : 769 - 772
  • [6] REVERSIBLE AND IRREVERSIBLE CHANGES OF STRIA VASCULARIS - EVALUATION OF EFFECTS OF ETHACRYNIC-ACID SEPARATELY AND IN COMBINATION WITH ATOXYL
    ANNIKO, M
    [J]. ACTA OTO-LARYNGOLOGICA, 1978, 85 (5-6) : 349 - 359
  • [7] TREATMENT OF MITOCHONDRIAL MYOPATHY DUE TO COMPLEX-III DEFICIENCY WITH VITAMINS K3 AND C - A P-31-NMR FOLLOW-UP-STUDY
    ARGOV, Z
    BANK, WJ
    MARIS, J
    ELEFF, S
    KENNAWAY, NG
    OLSON, RE
    CHANCE, B
    [J]. ANNALS OF NEUROLOGY, 1986, 19 (06) : 598 - 602
  • [8] Lack of complex I activity in human cells carrying a mutation in MtDNA-encoded ND4 subunit is corrected by the Saccharomyces cerevisiae NADH-quinone oxidoreductase (NDI1) gene
    Bai, YD
    Hájek, P
    Chomyn, A
    Chan, E
    Seo, BB
    Matsuno-Yagi, A
    Yagi, T
    Attardi, G
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (42) : 38808 - 38813
  • [9] Mitochondria in human offspring derived from ooplasmic transplantation
    Barritt, JA
    Brenner, CA
    Malter, HE
    Cohen, J
    [J]. HUMAN REPRODUCTION, 2001, 16 (03) : 513 - 516
  • [10] P-31 NMR-SPECTROSCOPY AND ERGOMETER EXERCISE TEST AS EVIDENCE FOR MUSCLE OXIDATIVE PERFORMANCE IMPROVEMENT WITH COENZYME-Q IN MITOCHONDRIAL MYOPATHIES
    BENDAHAN, D
    DESNUELLE, C
    VANUXEM, D
    CONFORTGOUNY, S
    FIGARELLABRANGER, D
    PELLISSIER, JF
    KOZAKRIBBENS, G
    POUGET, J
    SERRATRICE, G
    COZZONE, PJ
    [J]. NEUROLOGY, 1992, 42 (06) : 1203 - 1208